Rheumatology Medical News about abatacept

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Targeting lymphocyte activation to treat rheumatoid arthritis
Joint, Bone, Spine, 06/25/09

Falgarone G et al. - In RA patients, abatacept is effective in decreasing the arthritis, pain, disability, fatigue, and radiological joint damage. Abatacept provides lasting remissions or low levels of disease activity and therefore constitutes a valuable addition to the current therapeutic armamentarium for RA, which is hoped to make a full remission an attainable goal in the overall population of RA patients.

<< Previous
The epidemiology of Takayasu arteritis in the UK

Next >>
Vasculitis in children

Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09 Relevance Score: 94%

New Biologic Drug Is Effective Against Rheumatoid Arthritis
ScienceDaily, 10/07/09 Relevance Score: 80%